FTC Urges DC Circ. Not To Prolong Endo-Impax Monopoly

By Matthew Perlman · March 17, 2023, 6:55 PM EDT

The Federal Trade Commission urged the D.C. Circuit not to push back oral argument for the agency's bid to revive a case accusing Endo and Impax of splitting monopoly profits for...

To view the full article, register now.

Documents

Case Information

Case Title

FTC v. Endo Pharmaceuticals Inc., et al

Case Number

22-5137

Court

Appellate - DC Circuit

Nature of Suit

1410 Antitrust

Date Filed

May 24, 2022